Relationship between anxiety and thyroid function in patients with panic disorder.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):77-81. Related Articles, Substance (MeSH Keyword), LinkOut

Relationship between anxiety and thyroid function in patients with panic disorder.

Kikuchi M, Komuro R, Oka H, Kidani T, Hanaoka A, Koshino Y.

Department of Psychiatry and Neurobiology, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan. mitsuru@zc4.so-net.ne.jp

The aim of this study was to investigate correlations between thyroid function and severity of anxiety or panic attacks in patients with panic disorder. The authors examined 66 out-patients with panic disorder (medicated, n=41; non-medicated, n=25), and measured their free thriiodothyronine (T3), free thyroxine (T4) and thyroid-stimulating hormone (TSH) levels. Significant correlations between the thyroid hormone levels and clinical features were observed in the non-medicated patients. The more severe current panic attacks were, the higher the TSH levels were. In addition, severity of anxiety correlated negatively with free T4 levels. In this study, we discuss relationship between thyroid function and the clinical severity or features of panic disorder.

Publication Types:

  • Clinical Trial


PMID: 15610948 [PubMed – indexed for MEDLINE]

Posted in News | Tagged |

Altered diurnal variation of nitric oxide production in patients with panic disorder.

Tohoku J Exp Med. 2004 Oct;204(2):147-54. Related Articles, Compound (MeSH Keyword), Substance (MeSH Keyword), LinkOut

Altered diurnal variation of nitric oxide production in patients with panic disorder.

Kaya B, Unal S, Karabulut AB, Türköz Y.

Department of Psychiatry, Inonu University Medical School, Malatya, Turkey.

The aim of this prospective study was to investigate the diurnal change in serum nitric oxide (NO) levels in active and remission phases of patients with panic disorder. This study included 15 patients fulfilling the criteria for panic disorder of Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition and 15 healthy controls matched for age and sex. All patients were receiving a selective serotonin reuptake inhibitor at therapeutic doses. The serum nitrite and nitrate levels of subjects were determined at 10:00 a.m. after overnight fasting and at 3:00 p.m. 2 hours after lunch. NO levels of all patients measured in the morning were significantly higher than those of controls. The patients were also divided into active and remission groups according to clinical status and Panic Agoraphobia Scale’s cut-off point. There were no statistically significant differences in serum nitrite and nitrate levels of the active group between the 10:00 a.m. and 3:00 p.m. measurements. In contrast, statistically significant differences were found in the serum levels of nitrite (p<0.05) and nitrate (p<0.05) in the remission group. Notably, the afternoon nitrite and nitrate levels of the remission group were higher than those of the morning levels as seen in control subjects. Thus, diurnal variation of NO production is altered in patients with panic disorder but is resumed in the remission phase. The present study suggests that serum NO levels are a good marker for evaluation of panic disorder. Copyright 2004 Tohoku University Medical Press

PMID: 15383695 [PubMed – indexed for MEDLINE]

Posted in News | Tagged |

Panic disorder respiratory subtype: a comparison between responses to hyperventilation and CO2 challenge tests.

Related Articles, Links
Click here to read
Panic disorder respiratory subtype: a comparison between responses to hyperventilation and CO2 challenge tests.

Freire RC, Lopes FL, Valença AM, Nascimento I, Veras AB, Mezzasalma MA, de-Melo-Neto VL, Zin WA, Nardi AE.

Laboratory of Panic & Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rua Visconde de Pirajá, 407/702, 22410-003, Rio de Janeiro, Brazil. rafaelcrfreire@terra.com.br

In this study 117 panic disorder patients were divided into a respiratory subtype group and a non-respiratory subtype group. The respiratory subtype patients were observed to be more sensitive to the 35% CO(2) inhalation challenge test and the hyperventilation test than the non-respiratory subtype patients.

Publication Types:

PMID: 17964660 [PubMed – indexed for MEDLINE]

Posted in News | Tagged |

New-onset anxiety disorders at high altitude.

Related Articles, Links
New-onset anxiety disorders at high altitude.

Fagenholz PJ, Murray AF, Gutman JA, Findley JK, Harris NS.

Departments of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02140, USA.

OBJECTIVE: Studies on the neurologic effects of high-altitude travel have focused on psychometric and cognitive testing and the long-term effects of hypoxia on memory and cognition. Few authors have discussed overt clinical psychiatric illness during high-altitude travel, and those few have focused on patients with preexisting psychiatric diagnoses. We describe a series of patients with new-onset anxiety disorders at high altitude treated at the Himalayan Rescue Association (HRA) clinic in Pheriche, Nepal (4240 m) in the spring season of 2006. METHODS: We report on all 6 cases of anxiety-related illness diagnosed at the HRA Pheriche Clinic during the spring season, 2006. Three cases, representing the 3 discrete types of illness we encountered, are described in detail. RESULTS: Six of 76 foreign patients and none of the 224 Nepalis seen during the season had anxiety-related primary diagnoses. None of the 6 patients had a history of psychiatric disorders or anxiety-related problems at low altitude. Three of the 6 patients were seen after hours, and all 6 required multiple visits. We describe 3 types of anxiety-related disorders: limited-symptom panic attacks induced by nocturnal periodic breathing, excessive health-related anxiety, and excessive emotionality. CONCLUSIONS: Anxiety-related illness requires significant use of medical resources by high-altitude travelers. Further research is needed to define the epidemiology of anxiety-related disorders at high altitude, to quantify the contributions of various etiologic factors, and to identify safe, effective treatments.

Publication Types:

PMID: 18076297 [PubMed – indexed for MEDLINE]

Posted in News | Tagged |

Reducing anxiety sensitivity with exercise.

Related Articles, Links
Click here to read
Reducing anxiety sensitivity with exercise.

Smits JA, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW.

Department of Psychology, Southern Methodist University, Dallas, Texas 75275, USA. jsmits@smu.edu

BACKGROUND: Exercise interventions repeatedly have been shown to be efficacious for the treatment of depression, and initial studies indicate similar efficacy for the treatment of anxiety conditions. To further study the potential beneficial role of prescriptive exercise for anxiety-related conditions, we examined the role of exercise in reducing fears of anxiety-related sensations (anxiety sensitivity). METHODS: We randomly assigned 60 participants with elevated levels of anxiety sensitivity to a 2-week exercise intervention, a 2-week exercise plus cognitive restructuring intervention, or a waitlist control condition. Assessment of outcome was completed at pretreatment, midtreatment, 1-week posttreatment, and 3-week follow-up. RESULTS: We found that both exercise conditions led to clinically significant changes in anxiety sensitivity that were superior to the waitlist condition, representing a large controlled effect size (d=2.15). Adding a cognitive component did not facilitate the effects of the exercise intervention. Consistent with hypotheses, changes in anxiety sensitivity mediated the beneficial effects of exercise on anxious and depressed mood. CONCLUSIONS: We discuss these findings in terms of the potential role of exercise as an additional psychosocial intervention for conditions such as panic disorder, where anxiety sensitivity is a prominent component of pathology. Copyright 2008 Wiley-Liss, Inc.

PMID: 18729145 [PubMed – in process]

Posted in News | Tagged |